Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer

NCT00003011 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

555

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: marimastat
DRUG: Placebo

Sponsor

NCIC Clinical Trials Group